Ad
AEZS Quote Trading Chart Aeterna Zentaris Inc.
home / stock / aezs / aezs quote
$4.99 Last:
12.95% Change Percent:
$5.04 Open:
$4.4179 Previous Close:
$5.04 High:
$4.93 Low:
27,556 Volume:
12/31/1969 07:00:00 pm Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
AEZS Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2022-08-12 | 5.04 | 4.4179 | 5.04 | 4.93 | 27,556 |
| 2022-08-11 | 5.1101 | 4.4179 | 5.15 | 4.93 | 69,752 |
| 2022-08-10 | 4.82 | 4.4179 | 5.23 | 4.82 | 108,487 |
| 2022-08-09 | 5.0646 | 4.4179 | 5.0646 | 4.8796 | 46,397 |
| 2022-08-08 | 4.85 | 4.4179 | 5.07 | 4.8121 | 69,574 |
| 2022-08-05 | 4.71 | 4.4179 | 5.09 | 4.6801 | 181,442 |
| 2022-08-04 | 5.06 | 4.4179 | 5.9 | 4.59 | 520,864 |
| 2022-08-03 | 4.63 | 4.4179 | 5.4 | 4.494 | 384,328 |
| 2022-08-02 | 4.4009 | 4.4179 | 4.65 | 4.4009 | 45,943 |
| 2022-08-01 | 4.33 | 4.4179 | 4.6 | 4.29 | 41,671 |
| 2022-07-29 | 4.47 | 4.4179 | 4.52 | 4.31 | 66,780 |
| 2022-07-28 | 4.4179 | 4.4179 | 4.68 | 4.4 | 135,553 |
| 2022-07-26 | 4.34 | 4.34 | 4.4 | 4.21 | 28,489 |
| 2022-07-25 | 4.94 | 4.45 | 4.94 | 4.37 | 78,484 |
| 2022-07-19 | 0.1988 | 0.2005 | 0.2088 | 0.18 | 1,509,164 |
| 2022-07-18 | 0.2202 | 0.2218 | 0.2298 | 0.2125 | 1,330,453 |
| 2022-07-15 | 0.2248 | 0.2379 | 0.2379 | 0.215 | 779,064 |
| 2022-07-14 | 0.213 | 0.227 | 0.23 | 0.213 | 664,953 |
| 2022-07-13 | 0.2388 | 0.2169 | 0.2388 | 0.211 | 712,258 |
| 2022-07-12 | 0.2392 | 0.2274 | 0.2392 | 0.2106 | 805,001 |
Aeterna Zentaris Inc. Company Name:
AEZS Stock Symbol:
NASDAQ Market:
News, Short Squeeze, Breakout and More Instantly...
Ad
-
– Company ended the quarter with $58.2 million in cash – Driving c ontinued progress across diversified pre-clinical and clinical development pipeline TORONTO, ONTARIO, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (Nasdaq:...
-
TORONTO, ON, July 18, 2022 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“ Aeterna ” or the “ Company ”), a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests, today announced t...
-
TORONTO, ONTARIO, July 15, 2022 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (" Aeterna " or the " Company "), a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products, today an...